ProGrow Pharma (PGP) Partners, through exclusive focus and decade of experience in serving the Pharmaceutical Industry, caters the full spectrum of services for Pharma companies (Pharma/Biotech, Generic, CRAMS, CROs, Startups) and its Investors (Private Equity, Fund Managers, HNI).
The changing dynamics in the pharma industry across the world along with new government policies pose challenges for all pharma companies and investors. The high cost and risk associated with drug development, expiry of patents of blockbuster drugs has posed challenges as well as opportunities within the Pharma sector.
ProGrow Pharma Partners has the edge in creating and offering the effective and efficient foundation to pharmaceutical and biotech companies for their current business operations improvement and future growth potential, as well.Read more
With the domain knowledge under one platform, the team uses appropriate valuation methodology at a given point of time to assist clients in taking right investment decision.Read more
ProGrow Pharma Partners’ varied research methodologies, along with databases and resources allow to offer tailor-made research services.Read more
The whole world is currently, reading, hearing, and seeing about the developments in addressing the damaging effects of the covid-19 virus, and the info-pandemic is equally overwhelming. Confusion prevails in the treatment paradigm, clinical and anecdotal data of successful treatment and failures, recovery and timelines being promised for an effective therapy and prevention.
This is the first time in the lives of several generations that a calamity of this nature has affected the whole world. People in different geographies have faced calamities like – Tsunami, cyclones, drought, fire, terrorist attacks, etc where the effect was felt in small pockets. COVID-19 has turned the world upside down. Every aspect of our lives has been affected- How we interact with each other, work together, travel, etc. Decisions being taken right now will transform our future and will affect people all around the world for years to come.
Soaring drug prices and cost of healthcare is a worldwide concern and availability of generic drugs have helped in ..
Weight management by approved drugs Belviq / Belviq XR (Arena/ Eisai, June 2012 & XR – July 2016; Net sales FY16A
The application of nanotechnology in the field of Medicine has rewarded all “P’s”-patients’ physicians and pharmaceutical companies. Nanotherapeutics have helped in overcoming the major limitations of the 1st generation drugs developed for the disease. Despite the major benefits achieved like protecting the normal cells from the lethality of the chemotherapy drugs, research and development is aggressively being pursued to further improve on the efficacy, specificity, targeting only the tumor site, overcoming multidrug resistance etc. The list goes on lighting hopes for better outcomes for cancer treatments. In this report we focus on the evolution of nanotherapeutics in the treatment of cancer and the advances being made in this area.
The list of approved drugs is large but pales in front of the list of drugs under development and in the clinic. Needless to state that the commercial rewards for the approved drugs are fuelling the pipeline! In this report we discuss some of the drugs in the pipeline the companies and the market opportunity.
The success of targeted therapies in indications like cancer, chronic diseases have paved the way for using this approach in more challenging indications like Parkinson’s..
The spectrum of diseases caused by Human Cytomegalovirus (HCMV) is diverse.Most CMV infections are “silent,” where the infected people exhibit …